Drugmaker AstraZeneca has poached Alexion Pharmaceutical’s chief financial officer ahead of its acquisition, as the pharma firms shuffle their senior staff.
Joining with an £850,000 base salary,
The famed vaccine maker’s
Sarin’s appointment is still subject to certain regulatory approvals but will see her relocate from the US to the
The former CFO,
Dunoyer will then take over the helm of Alexion as CEO and chief strategy officer of AstraZenca.
“I’m looking forward to working with him in his new role as CEO, Alexion, the Rare Disease Unit of
Earlier this week, the UK’s Competition and Markets Authority and EU antitrust watchdogs were eyeing the billion-dollar deal, a
They will be reviewing the deal until 5 July, looking at whether to approve the Anglo-Swedish drugmaker’s $39bn bid for biopharmaceutical company Alexion.
The post
© City AM, source